Weiss Multi-Strategy Advisers’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-15,051
| Closed | -$142K | – | 733 |
|
2020
Q3 | $142K | Sell |
15,051
-3,941
| -21% | -$37.2K | ﹤0.01% | 515 |
|
2020
Q2 | $170K | Buy |
18,992
+648
| +4% | +$5.8K | ﹤0.01% | 499 |
|
2020
Q1 | $117K | Sell |
18,344
-11,656
| -39% | -$74.3K | ﹤0.01% | 384 |
|
2019
Q4 | $251K | Hold |
30,000
| – | – | ﹤0.01% | 492 |
|
2019
Q3 | $272K | Hold |
30,000
| – | – | 0.01% | 422 |
|
2019
Q2 | $323K | Buy |
+30,000
| New | +$323K | 0.01% | 369 |
|
2018
Q2 | – | Sell |
-10,000
| Closed | -$190K | – | 565 |
|
2018
Q1 | $190K | Sell |
10,000
-20,000
| -67% | -$380K | 0.01% | 424 |
|
2017
Q4 | $492K | Sell |
30,000
-20,000
| -40% | -$328K | 0.01% | 390 |
|
2017
Q3 | $750K | Sell |
50,000
-25,000
| -33% | -$375K | 0.03% | 333 |
|
2017
Q2 | $660K | Sell |
75,000
-10,000
| -12% | -$88K | 0.03% | 349 |
|
2017
Q1 | $442K | Hold |
85,000
| – | – | 0.02% | 376 |
|
2016
Q4 | $259K | Hold |
85,000
| – | – | 0.01% | 319 |
|
2016
Q3 | $394K | Buy |
85,000
+52,195
| +159% | +$242K | 0.02% | 294 |
|
2016
Q2 | $190K | Buy |
+32,805
| New | +$190K | 0.01% | 332 |
|
2014
Q2 | – | Sell |
-12,500
| Closed | -$226K | – | 810 |
|
2014
Q1 | $226K | Sell |
12,500
-570
| -4% | -$10.3K | ﹤0.01% | 827 |
|
2013
Q4 | $182K | Buy |
+13,070
| New | +$182K | ﹤0.01% | 852 |
|